ASCCP and NCI Publish Guidance in the Journal of Lower Genital Tract Disease; BD Onclarity HPV Assay Identifies Risk by HPV Type for Tailored Management CLARKSBURG, MARYLAND / ACCESS Newswire / ...

Fewer than half of women who tested positive for HPV with negative cytological findings returned for a surveillance co-test within 1 year as recommended, yet more than half of those who received ...

JANUARY is cervical cancer awareness month in Ireland – with around 250 women being diagnosed with the illness every year. It ...

CervicalCheck clinical director says high-grade pre-cancer abnormalities in 25-year-olds has fallen from 5% to 1% thanks to ...

Among female patients with positive human papillomavirus (HPV) test results and negative intraepithelial lesion or malignancy ...

Cervical cancer screening traditionally relies on the Pap smear and HPV-DNA tests. While effective, these methods are fraught with challenges, including variability in human interpretation, false ...

Getting the HPV vaccine in early adolescence may lower the risk of HPV-related cancers before exposure occurs. Learn about ...

Cervical cancer, the fourth most common cancer in women, is closely linked to persistent HPV infections. Early detection ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

BD Onclarity™ HPV assay adheres to new guidelines by identifying more individual types of HPV than any other test on the market ... to the American Society for Colposcopy and Cervical Pathology ...